Company AI Risk Explorer
Loading the data…
Welcome to the Company AI Risk Explorer

This tool maps what large global companies say in public about AI risk. We reviewed public documents from roughly 200 of the world's largest companies. We coded every risk they acknowledge against the AI Risk Repository taxonomy.

Filter by company, sector, AI role, or risk. Compare what companies acknowledge against expert ratings of severity, sector vulnerability, and role responsibility.

← Back to the overview Company AI Risk Explorer

Companies × risks

Amgen

Amgen deploys third-party AI at enterprise scale (Microsoft Copilot) and uses NVIDIA platforms for R&D and omics workflows. It also develops specialised AI models for drug discovery, including the AMPLIFY protein language model created in partnership with Mila (Montreal AI Institute).

We reviewed 5 public documents from Amgen and found it acknowledges 3 of 24 AI risks, including discrimination and loss of privacy.

Sector: Agriculture, Mining, Construction and Manufacturing; Chemicals & pharmaceutical manufacturing

Roles: AI deployer; Specialized AI developer

AI risks Amgen acknowledges

  • Discrimination: “assessing potential impacts on individual rights, fairness, transparency, and risks such as algorithmic bias” (Amgen Personal Information Protection Policy)
  • Loss of privacy: “we may experience adverse effects on our business, including data breaches... unintentional disclosure of personal data” (Amgen 2024 Annual Report Letter and 10-K)
  • Weapons & cyberattacks: “attacks are growing in frequency, sophistication, and intensity... using techniques and tools-including artificial intelligence-that circumvent security controls, evade detection and remove forensic evidence.” (Amgen 2024 Annual Report Letter and 10-K)

Documents we reviewed